FDA Inspection 810516 — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc — FEI 3009518416

The FDA completed an inspection of Ascent Pharmaceuticals Inc on Dec 6, 2012 in Central Islip, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Central Islip, NY (United States)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
355721 CFR 211.52Washing and toilet facilities are deficient
434521 CFR 211.160(b)(1)Samples (various types) representative, identified properly

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.